GreenMark Biomedical Inc.
- Raised $500,000 (2022)
- FDA-cleared or approved devices
- Research grants: $4.5 million
- Founded 2016
Life science companies
Explore 35,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Metabolon, Inc
- Raised $7.5 million (2025)
- Research grants: $1.4 million
Travere Therapeutics, Inc.
Nasdaq: TVTX
- Raised $25 million (2013)
- 14 clinical trials, 6 active
Azevan Pharmaceuticals Inc
- Raised $2.2 million (2013)
- 9 clinical trials, 1 active
- Research grants: $23 million
Aardvark Therapeutics, Inc.
Nasdaq: AARD
- Raised $85 million (2024)
- 6 clinical trials
- Founded 2017
Biovie Inc.
Nasdaq: BIVI
- Raised $6 million (2022)
- 6 clinical trials
- Founded 2013
Climb Bio, Inc.
Nasdaq: CLYM
- Raised $110 million (2026)
- 6 clinical trials, 5 active
- Founded 2018
Compass Therapeutics, Inc.
Nasdaq: CMPX
- Raised $110 million (2018)
- 7 clinical trials, 4 active
- Founded 2014
Jade Biosciences, Inc.
Nasdaq: JBIO
- Raised $76 million (2020)
- 6 clinical trials, 4 active
- Founded 2018
Lite Strategy, Inc.
Nasdaq: LITS
- Raised $75 million (2018)
- 13 clinical trials
Oligomerix, Inc.
- Raised $75,000 (2024)
- 1 clinical trial, 1 active
- Research grants: $40 million
TherapeuticsMD, Inc.
Nasdaq: TXMD
- Raised $1.1 million (2023)
- 6 clinical trials
- Founded 2010
TuHURA Biosciences, Inc./NV
Nasdaq: HURA
- Raised $1.5 million (2025)
- 6 clinical trials, 2 active
- Founded 2009
Neutrolis Inc.
- Raised $3.5 million (2025)
- 2 clinical trials, 1 active
- Research grants: $922,488
- Founded 2017
Outset Medical, Inc.
Nasdaq: OM
- Raised $3.9 million (2025)
- FDA-cleared or approved devices
United Health Products, Inc.
OTC: UEEC
- Raised $56,725 (2016)
- 1 clinical trial
- 1 FDA-registered device site
Altimmune, Inc.
Nasdaq: ALT
- Raised $19 million (2009)
- 25 clinical trials, 2 active
- Founded 2005
Actuate Therapeutics, Inc.
Nasdaq: ACTU
- Raised $4.7 million (2025)
- 5 clinical trials, 2 active
- Founded 2015
Allay Therapeutics, Inc.
- Raised $45 million (2025)
- 2 clinical trials
- Research grants: $502,226
Anavex Life Sciences Corp.
Nasdaq: AVXL
- Raised $10 million (2014)
- 13 clinical trials, 1 active
Showing 700 of 35,266 companies
Load morePublished company profiles only; counts update daily. Data licences